163 related articles for article (PubMed ID: 27252563)
21. Knowledge, Attitudes, and Behaviors Related to Hepatitis C Screening and Treatment among Health Care Providers in Washington, DC.
Doshi RK; Ruben M; Drezner K; Lachmann A; Kuo I; Chanes-Mora P; Varga L; Saafir-Callaway B; Visconti A; Kharfen M
J Community Health; 2020 Aug; 45(4):785-794. PubMed ID: 32125591
[TBL] [Abstract][Full Text] [Related]
22. Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment.
Lam D; Wong RJ; Tessier A; Zapata Y; Saldana E; Gish RG
Gastroenterology Res; 2022 Dec; 15(6):343-352. PubMed ID: 36660471
[TBL] [Abstract][Full Text] [Related]
23. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
Versfeld A; McBride A; Scheibe A; Spearman CW
Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
[TBL] [Abstract][Full Text] [Related]
24. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
[TBL] [Abstract][Full Text] [Related]
25. "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.
Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
Int J Equity Health; 2021 Mar; 20(1):81. PubMed ID: 33740984
[TBL] [Abstract][Full Text] [Related]
26. Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.
Burton HJ; Khatiwada A; Chung D; Meissner EG
South Med J; 2022 Jun; 115(6):352-357. PubMed ID: 35649518
[TBL] [Abstract][Full Text] [Related]
27. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach.
Li W; Chang TS; Chang SZ; Chen CH; Chen MY
BMC Infect Dis; 2020 Oct; 20(1):737. PubMed ID: 33028228
[TBL] [Abstract][Full Text] [Related]
28. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
[TBL] [Abstract][Full Text] [Related]
29. HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.
Prussing C; Chan C; Pinchoff J; Kersanske L; Bornschlegel K; Balter S; Drobnik A; Fuld J
Epidemiol Infect; 2015 May; 143(7):1408-16. PubMed ID: 25170631
[TBL] [Abstract][Full Text] [Related]
30. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan.
Yu ML; Yeh ML; Tsai PC; Huang CI; Huang JF; Huang CF; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Lin WY; Hou NJ; Lin ZY; Chen SC; Dai CY; Chuang WL; Chang WY
Medicine (Baltimore); 2015 Apr; 94(13):e690. PubMed ID: 25837762
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).
Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D; Hollingworth W; Ijaz S; Liddell D; Mandal S; Martin N; Beer LJZ; Drysdale K; Fraser H; Glass R; Graham L; Gunson RN; Hamilton E; Harris H; Harris M; Harris R; Heinsbroek E; Hope V; Horwood J; Inglis SK; Innes H; Lane A; Meadows J; McAuley A; Metcalfe C; Migchelsen S; Murray A; Myring G; Palmateer NE; Presanis A; Radley A; Ramsay M; Samartsidis P; Simmons R; Sinka K; Vojt G; Ward Z; Whiteley D; Yeung A; Hutchinson SJ
BMJ Open; 2019 Sep; 9(9):e029538. PubMed ID: 31551376
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(8):189-94. PubMed ID: 19265779
[TBL] [Abstract][Full Text] [Related]
33. Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study.
Clements KM; Clark RE; Lavitas P; Kunte P; Graham CS; O'Connell E; Lenz K; Jeffrey P
J Manag Care Spec Pharm; 2016 Jun; 22(6):714-722b. PubMed ID: 27231798
[TBL] [Abstract][Full Text] [Related]
34. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
Safo SA; Batchelder A; Peyser D; Litwin AH
Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
[TBL] [Abstract][Full Text] [Related]
35. The Hepatitis C Clinical Exchange Network: A Local Health Department Partnership With Acute Care Hospitals to Promote Screening and Treatment of Hepatitis C Virus Infection.
Kela-Murphy N; Moore MS; Verma CM; Bresnahan MP; Harrison E; Schwartz J; Winters A
J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E413-E420. PubMed ID: 34347654
[TBL] [Abstract][Full Text] [Related]
36. Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels.
Zhao A; Wegener M; Brooks R; Mininberg L; Helou E; Maughan A; Villanueva M
Health Promot Pract; 2023 Sep; 24(5):1029-1038. PubMed ID: 37439687
[No Abstract] [Full Text] [Related]
37. Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE.
Teixeira PA; Bresnahan MP; Laraque F; Litwin AH; Shukla SJ; Schwartz JM; Reynoso S; Perumalswami PV; Weiss JM; Wyatt B; Schackman BR
Learn Health Syst; 2018 Jul; 2(3):. PubMed ID: 31106275
[TBL] [Abstract][Full Text] [Related]
38. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
Papatheodoridis GV; Tsochatzis E; Hardtke S; Wedemeyer H
Liver Int; 2014 Nov; 34(10):1452-63. PubMed ID: 24750532
[TBL] [Abstract][Full Text] [Related]
39. Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review.
Yanes-Lane M; Dussault C; Linthwaite B; Cox J; Klein MB; Sebastiani G; Lebouché B; Kronfli N
J Viral Hepat; 2020 Feb; 27(2):205-220. PubMed ID: 31638294
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
